ReviewFrontiers in immunology2023

Impacting T-cell fitness in multiple myeloma: potential roles for selinexor and XPO1 inhibitors.

Adam F Binder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.